Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Other Gross PP&E Adjustments (2016 - 2025)

Marimed (MRMD) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with $108.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 1.96% to $108.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $108.0 million, a 1.96% decrease, with the full-year FY2024 number at $111.7 million, up 10.94% from a year prior.
  • Other Gross PP&E Adjustments was $108.0 million for Q3 2025 at Marimed, up from $106.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $111.7 million in Q4 2024 to a low of $42.5 million in Q1 2021.
  • A 5-year average of $84.2 million and a median of $87.0 million in 2023 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 66.08% in 2021, then fell 1.96% in 2025.
  • Marimed's Other Gross PP&E Adjustments stood at $58.5 million in 2021, then surged by 31.54% to $76.9 million in 2022, then skyrocketed by 30.92% to $100.7 million in 2023, then increased by 10.94% to $111.7 million in 2024, then decreased by 3.38% to $108.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Gross PP&E Adjustments are $108.0 million (Q3 2025), $106.3 million (Q2 2025), and $109.6 million (Q1 2025).